NewsRamp Psychedelics Podcast
Subscribed: 0Played: 0
Subscribe
Description
Explore the emerging world of psychedelics with the 'NewsRamp Psychedelics Podcast.' This podcast delivers the latest news and insights from NewsRamp.com, focusing on research developments, therapeutic applications, and regulatory changes in the psychedelics field. Stay informed on the groundbreaking advancements in this evolving industry.
59 Episodes
Reverse
Optimi Health Corp. is set to launch a Phase 2 clinical trial for major depressive disorder using psilocybin-assisted therapy, aiming for potential registration and exclusive ownership of trial results, with funding from current reserves.
Helus Pharma's CEO Michael Halstead will participate in a fireside chat at the Cantor Global Healthcare Conference on September 11, discussing the company's development of serotonergic agonists for mental health conditions. The webcast will be available for replay on the company's investor relations website.
Silo Pharma Inc. is researching ibogaine-based treatments for traumatic brain injury and related conditions, aiming to address underserved health issues.
Silo Pharma Inc. highlights U.S. federal momentum backing the development of psychedelic-based therapies for mental health and substance use disorders, anticipating innovation in treating conditions such as PTSD and addiction.
Silo Pharma Inc. highlights U.S. federal actions advancing the development of psychedelic-based therapies for mental health and substance use disorders, anticipating innovation in PTSD and addiction treatment.
Comments
Download from Google Play
Download from App Store
United States